Study Summary
This trial will test if a drug can raise testosterone in men with prostate cancer.
Eligible Conditions
- Prostate Adenocarcinoma
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: 28 days
28 days
To evaluate the effect of Osanetant on FSH levels.
Luteinizing hormone
To evaluate the effect of Osanetant on PSA levels.
Estradiol
Testosterone
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Pilot Trial: Osanetant 28 Days
1 of 1
Experimental Treatment
10 Total Participants · 1 Treatment Group
Primary Treatment: Pilot Trial: Osanetant 28 Days · No Placebo Group · Phase < 1
Pilot Trial: Osanetant 28 Days
Drug
Experimental Group · 1 Intervention: Osanetant · Intervention Types: DrugTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 28 days
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
407 Previous Clinical Trials
160,153 Total Patients Enrolled
Eligibility Criteria
Age 18+ · Male Participants · 15 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any openings left for prospective participants in this experiment?
"This medical study, which was uploaded to clinicaltrials.gov on the 1st of November 2022 and last updated 4 days later, is not presently recruiting participants. Nonetheless, there are 810 other trials actively welcoming applicants at this time." - Anonymous Online Contributor
Unverified Answer